Chen Chen
Stock Analyst at UBS
(4.60)
# 934
Out of 4,712 analysts
45
Total ratings
75%
Success rate
43%
Average return
Main Sectors:
Stocks Rated by Chen Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $160.80 → $149.00 | $93.95 | +58.60% | 7 | Sep 3, 2026 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $51.10 → $62.00 | $47.42 | +30.75% | 5 | Sep 1, 2026 | |
| HKG: 3759 Pharmaron Beijing Co., Ltd. | Downgraded: Hold | $35.30 | $27.94 | +26.34% | 1 | Aug 25, 2026 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Reiterated: Hold | $34.70 | $17.10 | +102.92% | 4 | Mar 13, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Reiterated: Buy | $23.60 | $13.65 | +72.89% | 5 | Dec 14, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Reiterated: Hold | $63.80 | $75.10 | -15.05% | 6 | Dec 9, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Reiterated: Buy | $50.00 → $56.30 | $41.82 | n/a | 4 | Sep 1, 2025 | |
| HKG: 6127 Joinn Laboratories(China)Co.,Ltd. | Reiterated: Hold | $14.30 → $16.30 | $21.72 | n/a | 5 | Jul 14, 2025 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Upgraded: Buy | $40.10 → $70.40 | $191.70 | n/a | 2 | Nov 1, 2024 | |
| HKG: 2252 Shanghai MicroPort MedBot (Group) Co., Ltd. | Reiterated: Buy | $20.00 → $9.50 | $21.18 | n/a | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35.70 | $21.10 | n/a | 1 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $286 | $351.00 | n/a | 1 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $123.10 | $470.00 | n/a | 1 | Nov 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 219p | 818p | n/a | 1 | Aug 30, 2021 |
Akeso, Inc.
Sep 3, 2026
Reiterated: Buy
Price Target: $160.80 → $149.00
Current: $93.95
Upside: +58.60%
WuXi Biologics (Cayman) Inc.
Sep 1, 2026
Reiterated: Buy
Price Target: $51.10 → $62.00
Current: $47.42
Upside: +30.75%
Pharmaron Beijing Co., Ltd.
Aug 25, 2026
Downgraded: Hold
Price Target: $35.30
Current: $27.94
Upside: +26.34%
Shanghai Junshi Biosciences Co., Ltd.
Mar 13, 2026
Reiterated: Hold
Price Target: $34.70
Current: $17.10
Upside: +102.92%
InnoCare Pharma Limited
Dec 14, 2025
Reiterated: Buy
Price Target: $23.60
Current: $13.65
Upside: +72.89%
RemeGen Co., Ltd.
Dec 9, 2025
Reiterated: Hold
Price Target: $63.80
Current: $75.10
Upside: -15.05%
Hangzhou Tigermed Consulting Co., Ltd
Sep 1, 2025
Reiterated: Buy
Price Target: $50.00 → $56.30
Current: $41.82
Upside: n/a
Joinn Laboratories(China)Co.,Ltd.
Jul 14, 2025
Reiterated: Hold
Price Target: $14.30 → $16.30
Current: $21.72
Upside: n/a
WuXi AppTec Co., Ltd.
Nov 1, 2024
Upgraded: Buy
Price Target: $40.10 → $70.40
Current: $191.70
Upside: n/a
Shanghai MicroPort MedBot (Group) Co., Ltd.
Sep 11, 2024
Reiterated: Buy
Price Target: $20.00 → $9.50
Current: $21.18
Upside: n/a
Apr 23, 2024
Initiated Coverage: Buy
Price Target: $35.70
Current: $21.10
Upside: n/a
Feb 29, 2024
Reiterated: Buy
Price Target: $286
Current: $351.00
Upside: n/a
Nov 23, 2023
Initiated Coverage: Buy
Price Target: $123.10
Current: $470.00
Upside: n/a
Aug 30, 2021
Reiterated: Hold
Price Target: 219p
Current: 818p
Upside: n/a